Cullinan Therapeutics, Inc.

CGEM

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001789972

SEC filings (opens in a new tab)

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Cullinan Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of CGEM: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	82	2	89	+9
Shares	36.9M	68.7K	37.6M	+769.7K (+2.1%)
Value	$386.3M	$719.0K	$481.7M	+$96.1M (+24.9%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CGEM in Q2 2022
Institution	Shares	Value	% of portfolio
EcoR1 Capital, LLC	1,169,889	$15.0M	0.52%
Tang Capital Management LLC	609,231	$7.81M	1.19%
Rubric Capital Management LP	297,347	$3.81M	0.20%
Renaissance Technologies LLC	293,600	$3.76M	0.00%
Silverarc Capital Management, LLC	213,090	$2.73M	1.28%
Atom Investors LP	96,880	$1.24M	0.54%
Soleus Capital Management, L.P.	95,485	$1.22M	0.20%
D. E. Shaw & Co., Inc.	94,986	$1.22M	0.00%
Marshall Wace, LLP	43,123	$553.0K	0.00%
Kennedy Capital Management, Inc.	34,347	$440.0K	0.01%
Trexquant Investment LP	31,851	$408.0K	0.02%
Alps Advisors Inc	26,565	$341.0K	0.00%
Two Sigma Securities, LLC	24,640	$316.0K	0.06%
AQR Capital Management LLC	20,909	$268.0K	0.00%
Nisa Investment Advisors, LLC	13,900	$178.0K	0.00%
SG Americas Securities, LLC	12,608	$162.0K	0.00%
Voya Investment Management LLC	11,209	$144.0K	0.00%
Simplex Trading, LLC	289	$3.00K	0.00%
Rockefeller Capital Management L.P.	221	$2.00K	0.00%
Signaturefd, LLC	40	$1.00K	0.00%
Allworth Financial LP	46	$1.00K	0.00%
CWM, LLC	20	$0	0.00%
Capital Advisors, Ltd. LLC	37	$0	0.00%

Sold out (14)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CGEM in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Eventide Asset Management, LLC	1,440,145	$15.1M
Foresite Capital Management V, LLC	992,507	$10.4M
Rock Springs Capital Management LP	652,578	$6.83M
Deerfield Management Company, L.P. (Series C)	375,585	$3.93M
Ra Capital Management, L.P.	350,000	$3.67M
Foresite Capital Opportunity Management V, LLC	330,836	$3.46M
Logos Global Management LP	200,000	$2.09M
Rafferty Asset Management, LLC	55,152	$577.0K
Victory Capital Management Inc	29,930	$313.0K
Qube Research & Technologies Ltd	16,628	$174.0K
Susquehanna International Group, LLP	15,182	$159.0K
HRT Financial LP	14,180	$148.0K
Prospera Financial Services Inc	1,168	$12.0K
Group One Trading, L.P.	100	$1.00K

Not filed for Q2 2022 yet (2)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	65,443	$685.0K
Amalgamated Financial Corp.	3,207	$34.0K